Intramuscular administration of recombinant Newcastle disease virus expressing SARS-CoV-2 spike protein protects hACE-2 TG mice against SARS-CoV-2 infection

Coronavirus disease 2019 (Covid-19) caused by the severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) became a pandemic, causing significant burden on public health worldwide. Although the timely development and production of mRNA and adenoviral vector vaccines against SARS-CoV-2 have been...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Vaccine 2023-07, Vol.41 (33), p.4787-4797
Hauptverfasser:	Kim, Deok-Hwan, Lee, Jiho, Youk, Sungsu, Jeong, Jei-hyun, Lee, Da-ye, Ju, Hyo-seon, Youn, Ha-na, Kim, Jin-cheol, Park, Soo-bin, Park, Ji-eun, Kim, Ji-yun, Kim, Tae-hyeon, Lee, Seung-hun, Lee, Hyukchae, Mouhamed Abdallah Amal Abdal, Lah, Lee, Dong-Hun, Park, Pil-Gu, Hong, Kee-Jong, Song, Chang-Seon
Format:	Artikel
Sprache:	eng
Schlagworte:	Animals Antibodies Antibodies, Neutralizing Antibodies, Viral Coronaviruses COVID-19 COVID-19 - prevention & control COVID-19 Vaccines Disease Eggs Genes Genomes Heat resistance Humans Immunization Infections Intramuscular vaccine K18-hACE-2 TG mice Laboratories Load distribution Lung viral load Mice Mice, Transgenic mRNA Newcastle disease Newcastle disease virus - genetics Newcastle disease virus-vectored vaccine Pandemics Pathogens Plasmids Proteins Public health Respiratory diseases SARS-CoV-2 Severe acute respiratory syndrome coronavirus 2 Spike Glycoprotein, Coronavirus - genetics Spike protein Sucrose Survival Transgenic mice Vaccines Vectors (Biology) Viral diseases Viral Vaccines - genetics Virulence Viruses
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!